143 related articles for article (PubMed ID: 31334110)
1. LNMAT1 Promotes Invasion-Metastasis Cascade in Malignant Melanoma by Epigenetically Suppressing CADM1 Expression.
Mou K; Zhang X; Mu X; Ge R; Han D; Zhou Y; Wang L
Front Oncol; 2019; 9():569. PubMed ID: 31334110
[TBL] [Abstract][Full Text] [Related]
2. Corrigendum: LNMAT1 Promotes Invasion-Metastasis Cascade in Malignant Melanoma by Epigenetically Suppressing CADM1 Expression.
Mou K; Zhang X; Mu X; Ge R; Han D; Zhou Y; Wang LJ
Front Oncol; 2022; 12():905360. PubMed ID: 35619916
[TBL] [Abstract][Full Text] [Related]
3. LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment.
Chen C; He W; Huang J; Wang B; Li H; Cai Q; Su F; Bi J; Liu H; Zhang B; Jiang N; Zhong G; Zhao Y; Dong W; Lin T
Nat Commun; 2018 Sep; 9(1):3826. PubMed ID: 30237493
[TBL] [Abstract][Full Text] [Related]
4. CADM1 is a TWIST1-regulated suppressor of invasion and survival.
Hartsough EJ; Weiss MB; Heilman SA; Purwin TJ; Kugel CH; Rosenbaum SR; Erkes DA; Tiago M; HooKim K; Chervoneva I; Aplin AE
Cell Death Dis; 2019 Mar; 10(4):281. PubMed ID: 30911007
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA‑214 promotes the EMT process in melanoma by downregulating CADM1 expression.
Wang SJ; Li WW; Wen CJ; Diao YL; Zhao TL
Mol Med Rep; 2020 Nov; 22(5):3795-3803. PubMed ID: 33000202
[TBL] [Abstract][Full Text] [Related]
6. CADM1/TSLC1 inhibits melanoma cell line A375 invasion through the suppression of matrix metalloproteinases.
You Y; Zhang J; Li Y; Li Y; Shi G; Ma L; Wei H
Mol Med Rep; 2014 Nov; 10(5):2621-6. PubMed ID: 25215547
[TBL] [Abstract][Full Text] [Related]
7. Functional and Clinical Characteristics of Cell Adhesion Molecule CADM1 in Cancer.
Li H; Gao J; Zhang S
Front Cell Dev Biol; 2021; 9():714298. PubMed ID: 34395444
[TBL] [Abstract][Full Text] [Related]
8. CADM1 mRNA expression and clinicopathological significance in esophageal squamous cell carcinoma tissue.
Qian JB; Liu HB; Zhu Y; Lu F; Yang QC; Shen Y
Genet Mol Res; 2017 May; 16(2):. PubMed ID: 28510248
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-10b promotes migration and invasion through CADM1 in human hepatocellular carcinoma cells.
Li QJ; Zhou L; Yang F; Wang GX; Zheng H; Wang DS; He Y; Dou KF
Tumour Biol; 2012 Oct; 33(5):1455-65. PubMed ID: 22528944
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA SNHG15 inhibits P15 and KLF2 expression to promote pancreatic cancer proliferation through EZH2-mediated H3K27me3.
Ma Z; Huang H; Wang J; Zhou Y; Pu F; Zhao Q; Peng P; Hui B; Ji H; Wang K
Oncotarget; 2017 Oct; 8(48):84153-84167. PubMed ID: 29137412
[TBL] [Abstract][Full Text] [Related]
11. Epigenetically silenced linc00261 contributes to the metastasis of hepatocellular carcinoma via inducing the deficiency of FOXA2 transcription.
Chen Z; Xiang L; Hu Z; Ou H; Liu X; Yu L; Chen W; Jiang L; Yu Q; Fang Y; Xu Y; Liu Q; Huang Y; Li X; Yang D
Am J Cancer Res; 2021; 11(1):277-296. PubMed ID: 33520374
[TBL] [Abstract][Full Text] [Related]
12. LncRNA HOXD-AS1 promotes melanoma cell proliferation and invasion by suppressing RUNX3 expression.
Zhang H; Bai M; Zeng A; Si L; Yu N; Wang X
Am J Cancer Res; 2017; 7(12):2526-2535. PubMed ID: 29312805
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of CADM1 and CADM4 are associated with advanced stage breast cancer.
Saito M; Goto A; Abe N; Saito K; Maeda D; Ohtake T; Murakami Y; Takenoshita S
Oncol Lett; 2018 Feb; 15(2):2401-2406. PubMed ID: 29434950
[TBL] [Abstract][Full Text] [Related]
15. lncRNA CADM1-AS1 inhibits cell-cycle progression and invasion via PTEN/AKT/GSK-3β axis in hepatocellular carcinoma.
Wang F; Qi X; Li Z; Jin S; Xie Y; Zhong H
Cancer Manag Res; 2019; 11():3813-3828. PubMed ID: 31118799
[No Abstract] [Full Text] [Related]
16. The Role of Cell Adhesion Molecule 1 (CADM1) in Cutaneous Malignancies.
Sawada Y; Mashima E; Saito-Sasaki N; Nakamura M
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33419290
[TBL] [Abstract][Full Text] [Related]
17. Plasma CADM1 promoter hypermethylation and D-dimer as novel metastasis predictors of cervical cancer.
Rong G; Zhang M; Xia W; Li D; Miao J; Wang H
J Obstet Gynaecol Res; 2019 Jul; 45(7):1251-1259. PubMed ID: 30945386
[TBL] [Abstract][Full Text] [Related]
18. EZH2 promotes invasion and metastasis of laryngeal squamous cells carcinoma via epithelial-mesenchymal transition through H3K27me3.
Luo H; Jiang Y; Ma S; Chang H; Yi C; Cao H; Gao Y; Guo H; Hou J; Yan J; Sheng Y; Ren X
Biochem Biophys Res Commun; 2016 Oct; 479(2):253-259. PubMed ID: 27638307
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-126 regulates migration and invasion of gastric cancer by targeting CADM1.
Yang Z; Wang R; Zhang T; Dong X
Int J Clin Exp Pathol; 2015; 8(8):8869-80. PubMed ID: 26464628
[TBL] [Abstract][Full Text] [Related]
20. CADM1 inhibits ovarian cancer cell proliferation and migration by potentially regulating the PI3K/Akt/mTOR pathway.
Si X; Xu F; Xu F; Wei M; Ge Y; Chenge S
Biomed Pharmacother; 2020 Mar; 123():109717. PubMed ID: 31865146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
